ライフサイエンスコーパス: shortness

1 Read shortness and sequencing errors pose a major challenge t

2 hydrogen bonds, despite their extraordinary shortness (as short as 2.0 A).

3 Telomere shortness in human beings is a prognostic marker of agei

4 Telomere shortness in human beings is emerging as a prognostic ma

5 shape caused by force toward the PM and with shortness of active zone material macromolecules linking

6 5; p<0.1), sputum (3.15, 1.39-7.13; p<0.05), shortness of breath (1.86, 0.97-3.57; p<0.1), and wheeze

7 ratio 2.07 [95% CI 1.41-3.05]), waking with shortness of breath (2.32 [1.25-4.34]), and asthma attac

8 mplain of fatigue (54% v 20%; P = .0002) and shortness of breath (22% v 8%; P = .02).

9 igue (70.7%), sleep disturbance (47.8%), and shortness of breath (42.1%).

10 These included cough (64%), shortness of breath (56%), and temperature elevation (33

11 The most frequent acute symptoms were shortness of breath (57.9%), weakness (54.8%), and fatig

12 le and/or irritation (92.1%), cough (78.5%), shortness of breath (72.5%), and pain on deep inspiratio

13 0%), chest tightness (93%), cough (80%), and shortness of breath (73%).

14 rrelated with increasing fatigue, increasing shortness of breath (both, r = -0.35; P =.

15 with each subject waking and complaining of shortness of breath (mean time to arousal, 115 s; range,

16 verweight/obese children more often reported shortness of breath (odds ratio = 11.8; 95% CI, 1.41-98.

17 CI, 1.3 to 2.2), attacks of wheezing causing shortness of breath (OR, 1.6; 95% CI, 1.2 to 2.1) or awa

18 % confidence interval [95% CI], 1.15, 4.47), shortness of breath (OR, 2.33; 95% CI, 1.12, 5.06), and

19 CI; 1.3 to 4.3), attacks of wheezing causing shortness of breath (OR, 2.4; 95% CI, 1.3 to 4.4) or awa

20 ell as male sex (P = .025), wheezing causing shortness of breath (P = .002), and ACS at less than 4 y

21 in the relative risks for severe wheeze with shortness of breath (relative risk 0.44 [95% CI 0.20-1.0

22 s of estrogen treatment (abdominal pain 60%, shortness of breath 40%, or both 35%).

23 % confidence interval (CI): 1.11, 1.21]} and shortness of breath [OR=1.61 per 5mug/m(3) (95% CI: 1.45

24 The association between shortness of breath and a 5-mug/m(3) increment in PM2.5

25 tween prevalence of self-reported wheeze and shortness of breath and annual mean particulate matter w

26 Greater shortness of breath and beta-agonist use appears to be p

27 rgency department in December with worsening shortness of breath and chest heaviness for 1 week.

28 such abnormalities were more likely to have shortness of breath and chronic cough and reduced measur

29 d BV may contribute to exercise intolerance, shortness of breath and chronic fatigue, secondary to re

30 nter of UCSD Medical Center with significant shortness of breath and limitation of daily activities.

31 or wall myocardial infarction presented with shortness of breath and palpitations.

32 our averages) were associated with increased shortness of breath and rescue medication use.

33 bo, n=1), which was unrelated to study drug (shortness of breath and throat tightness after severe co

34 Early symptoms of shortness of breath and wheezing progressed over 2 wk to

35 k of fatigue, sexual dysfunction, dysphagia, shortness of breath and/or hypotension, procedure-relate

36 hite (odds ratio, 2.2; 1.1 to 4.3), reported shortness of breath as their chief symptom (odds ratio,

37 versus those without lesions), particularly "shortness of breath at night" (odds ratio (OR) = 2.8, 95

38 She is somewhat limited by the shortness of breath but maintains an Eastern Cooperative

39 ges in both patients, but angina or abnormal shortness of breath did not develop in either patient du

40 wenty-two (22%) of 98 patients complained of shortness of breath during everyday activities compared

41 -MB) and one of the following: chest pain or shortness of breath during the preceding 24 h or electro

42 (OR = 2.8, 95% CI: 1.2, 6.6) in smokers and "shortness of breath ever" (OR = 3.8, 95% CI: 0.7, 20.6)

43 Patients with symptoms of abdominal pain and shortness of breath had significantly increased hepatic

44 ver in 20 patients (87%), cough in 20 (87%), shortness of breath in 11 (48%), and gastrointestinal sy

45 linical features of MTX lung injury included shortness of breath in 27 patients (93.1%), which was pr

46 omatic, with cough reported in all patients, shortness of breath in 94%, and hemoptysis in 55%.

47 associated with the prevalence of wheeze and shortness of breath in this large study, with stronger a

48 atment was terminated prematurely because of shortness of breath in three patients in each group.

49 n unsuspected in patients with COPD, because shortness of breath is attributed to COPD.

50 en characterized by hypotension, nausea, and shortness of breath occurring within 30 minutes after ad

51 ion of microwave popcorn had higher rates of shortness of breath on exertion and skin problems that h

52 symptoms, defined as any reported wheezing, shortness of breath or dry nocturnal cough, were reporte

53 atic and denied fevers, sweats, weight loss, shortness of breath or dyspnea on exertion, or cough.

54 Slight improvement in shortness of breath or fatigue was associated with signi

55 ere most strongly influenced by the risks of shortness of breath or hypotension, fatigue, and procedu

56 76-year-old man consults you for increasing shortness of breath over the past two years and an incre

57 vel of asthma severity, whereas intensity of shortness of breath predicted HRQL at all levels of asth

58 dyspnea (University of California, San Diego Shortness of Breath Questionnaire [UCSD SOBQ]), 6-minute

59 s in the University of California, San Diego Shortness of Breath Questionnaire), health status (reduc

60 Some symptoms such as breathlessness and shortness of breath seem not to be evidence-based asthma

61 n exposures and the prevalence of wheeze and shortness of breath using harmonized baseline data from

62 An increased risk of shortness of breath was also associated with the combina

63 Shortness of breath was higher on days 7-21, with a dip

64 Shortness of breath was the most common presenting sympt

65 trial in which patients seen in the ED with shortness of breath were consented to have BNP levels dr

66 Fatigue and shortness of breath were significantly more common in pa

67 5-3.7) in men and 2.7 (2.3-3.1) in women for shortness of breath when walking upstairs; 4.5 (2.5-7.8)

68 He reports both mild shortness of breath with exertion and minimal chronic sw

69 c inflammatory condition defined by episodic shortness of breath with expiratory wheezing and cough,

70 y symptoms (persistent or recurring cough or shortness of breath), 2) chronic bronchitis or emphysema

71 tail bone, and one woman had chest pain and shortness of breath).

72 44%) were asymptomatic, but 8 (44%) reported shortness of breath, 7 (39%) reported cough, and 5 (28%)

73 f LVP performed, cumulative volume from LVP, shortness of breath, abdominal distention, abdominal pai

74 imes the expected rates of chronic cough and shortness of breath, according to comparisons with the n

75 ce of obesity, absence of diabetes mellitus, shortness of breath, and a short delay between pain onse

76 ypes, characterized by symptoms of wheezing, shortness of breath, and coughing due to airway hyperrea

77 tion, which can lead to reduced oxygenation, shortness of breath, and death.

78 soon thereafter she had a headache, nausea, shortness of breath, and dizziness.

79 s included headache, fever, chills, myalgia, shortness of breath, and fatigue.

80 l distention, a 5-pound weight gain, nausea, shortness of breath, and reduced urinary frequency.

81 th poor well-being, depression, anxiety, and shortness of breath, but not with other somatic symptoms

82 isode are similar, and both can present with shortness of breath, chest pain, cough, and wheezing.

83 uded fever in 13 patients (41%) and moderate shortness of breath, chest pain, or both in six (19%).

84 piratory symptoms (wheeze, persistent cough, shortness of breath, chest tightness).

85 ts with acute asthma will exhibit increasing shortness of breath, chest tightness, coughing, and/or w

86 Adults were often afebrile and complained of shortness of breath, chills, and severe pain.

87 % of participants experienced some degree of shortness of breath, cough, difficulty breathing, appeti

88 Shortness of breath, dyspnea, or respiratory distress or

89 lds, wheeze frequency, activity disturbance, shortness of breath, exercise-related and aeroallergen-r

90 Its symptoms, including shortness of breath, fatigue, and edema, can be frighten

91 Transient symptoms, such as shortness of breath, headache, and dizziness, were repor

92 characterized by similar symptoms (fatigue, shortness of breath, headache, sleep disturbance, forget

93 ood had similar occurrences of pneumothorax, shortness of breath, hemoptysis, nephrectomy, and death.

94 The patient presented with shortness of breath, malaise, and cough that had develop

95 f symptoms (pain, disturbed sleep, distress, shortness of breath, or constipation) reached a predeter

96 ry muscle function may result in symptoms of shortness of breath, reductions in vital capacity, and a

97 Thirst was moderately intense, and shortness of breath, scared, confusion, and pain were mo

98 second dose, she developed chest tightness, shortness of breath, tongue swelling, diffuse pruritic r

99 iables most predictive of CD: age, diabetes, shortness of breath, use of vasodilator stress, rest hea

100 ic pulmonary infiltrates, chronic cough, and shortness of breath.

101 showed positive associations with wheeze and shortness of breath.

102 of epigastric and midsternal chest pain with shortness of breath.

103 year-old man presents with left leg pain and shortness of breath.

104 present, then the most common complaint was shortness of breath.

105 nal pain, nausea, bilious emesis, cough, and shortness of breath.

106 des increased sputum purulence and worsening shortness of breath.

107 , wheeze, cough, tightness of the chest, and shortness of breath.

108 t of diastolic dysfunction and inappropriate shortness of breath.

109 c peptides in patients presenting with acute shortness of breath.

110 ardiac and noncardiac, presenting with acute shortness of breath.

111 sus non-systolic dysfunction presenting with shortness of breath.

112 , consistent in univariate analysis only for shortness of breath.

113 1.44 [95% confidence interval: 1.22, 1.70]; shortness of breath: 1.32 [1.12, 1.56]; dry cough: 1.16

114 ars; 63% women; 17% smokers; 77% phlegm; 70% shortness of breath; 47% wheezing; 46% chest pain; 42% a

115 ce of chimpanzees to humans and the relative shortness of our evolutionary separation suggest that mo

116 The shortness of recent human facial skeletons is the evolut

117 The shortness of region 2 would leave little of the peptide

118 s of magnitude because of the sparseness and shortness of sequencing reads.

119 singleton's location can be measured by the shortness of the reaction time in a visual search for si

120 ired-end sequencing allows circumventing the shortness of the reads produced by second generation seq

121 al biological and historical causes, such as shortness of time spans between divergences for evolutio

122 function (r=-0.87), vitality (r=-0.85), and shortness-of-breath (r=0.84) scales.

123 Health Survey questionnaire, an established shortness-of-breath scale, and the Minnesota Living with